TokenPost topic

Krystal Biotech

1 TokenPost story is tagged Krystal Biotech. The newest appear first.

Latest Krystal Biotech stories

• Krystal Biotech Q3 Estimates Point to 29.4% Revenue Growth

  Earnings per share are estimated at $1.92, down 27.8% year over year. Results are due before U.S. markets open Monday, Nov. 2.

  Oct 30, 2026, 1:45 PM EDT · Business